Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesNew perspectives in the treatment of advanced or metastatic gastric cancer
World Journal of Gastroenterology, 06/15/09
Rosati G et al. - Metastatic gastric cancer remains an incurable disease, with a relative 5-year survival rate of 7%-27%. Chemotherapy, which improves overall survival (OS) and quality of life, is the main treatment option. Meta-analysis has demonstrated that the best survival results obtained in earlier randomized studies were achieved with three-drug regimens containing a fluoropyrimidine, an anthracycline, and cisplatin (ECF). Although there has been little progress in improving median OS times beyond the 9-mo plateau achievable with the standard regimens, the availability of newer agents has provided some measure of optimism.
Related Articles
CHD5 is down-regulated through promoter hypermethylation in gastric cancer
BMC: Journal of Biomedical Science, 10/26/09
Relevance Score: 71%
Promoter hypermethylation mediates downregulation of thiamine receptor slc19a3 in gastric cancer
Tumor Biology, 10/12/09
Relevance Score: 71%
KAP1 Is Associated With Peritoneal Carcinomatosis in Gastric Cancer
Annals of Surgical Oncology, 11/11/09
Relevance Score: 69%
Management of patients with pregnancy-associated gastric cancer in Japan: a mini-review
International Journal of Clinical Oncology, 10/30/09
Relevance Score: 69%
A Study of Oxidative Stress Parameters in Anti-Helicobacter Pylorus Immunoglobulin G Positive and Negative Gastric Cancer Patients
Yonsei Medical Journal, 10/29/09
Relevance Score: 69%
Today in Chemotherapy/Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Phase II study of paclitaxel and vinorelbine (Pacl-Vin) in hormone-refractory metastatic prostate cancer: double tubulin targeting
Internal Medicine Journal, 03/19/10
Cetuximab combined with chemotherapy in non-small cell lung cancer
Community Oncology , 03/19/10
Angiogenesis-inhibitors for metastatic thyroid cancer
Cochrane Reviews, 03/19/10
Today in Stomach/GI...keeping you current
Receive free subspecialty "5-minute updates" via email
Toxicities of Gemcitabine in Patients with Severe Hepatic Dysfunction
Annals of Pharmacotherapy, 03/17/10
CYP3A4 catalytic activity is induced in confluent Huh7 hepatoma cells
Drug Metabolism and Disposition, 03/17/10
A comparison of whole genome gene expression profiles of HepaRG cells and HepG2 cells to primary human hepatocytes and human liver tissues
Drug Metabolism and Disposition, 03/17/10
Article Search
Sponsor
Sponsor